IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Cancer Clinical Trial Compensation: Undue or Long Overdue?

Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

Palliative Care Benefits Vary Depending on Providers, Timing

Spine Stereotactic Radiosurgery: A Critical Evaluation of the Evidence to Guide Clinical Practice

Radiotherapy Inaccessibility in Lung Cancer Care: An Ongoing Crisis

Cardiac Toxicity of Lung Cancer Radiotherapy

Hippocampal-Sparing Brain Irradiation: The Future of Brain Metastases Treatment and Prevention?

Prophylactic Radiotherapy: A Case for Patients at High Risk of Brain Metastases

The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Con Side

The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Pro Side

Deeper Dive Toxicity of Lung SBRT and Concurrent Immunotherapy Combinations: What We Know and What We Still Need to Learn